关于FBXO2与恶性瘤之间的关系的研究进展 (综述)
Jieya Zhang1, Jize Yang1, Xiaomin Zhang1
1Department of Hepatobiliary Surgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi 030032, P.R. China.
Molecular medicine reports
|September 26, 2025
概括
无素蛋白酶体系统调节蛋白质降解. F-box蛋白2 (FBXO2) 涉及恶性瘤,影响其扩散和入侵,提供潜在的治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 无素蛋白酶系统 (UPS) 对于蛋白质平衡至关重要,它涉及诸如E1,E2,E3结合酶和26S蛋白质酶等酶.
- S相酶相关蛋白1 (SKP1) - 库林-F-盒 (SCF) 复合体是关键的E3无素连接酶,参与癌症进展.
- F-box蛋白 (FBPs) 赋予SCF复合体的基质特异性,并参与重要的细胞过程.
研究的目的:
- 审查UPS和FBP家族的组成.
- 阐明FBP,特别是F-box蛋白2 (FBXO2) 在恶性瘤中的作用.
- 探索FBXO2与各种癌症之间的关系,以了解瘤发育机制并确定治疗策略.
主要方法:
- 关于无素蛋白酶体系统的文献综述.
- 分析F-盒蛋白家族的组成和功能.
- 检查FBXO2表达及其与瘤进展的关联.
主要成果:
- FBXO2是FBP泛基因酶的一个子单元,在细胞质中高度表达.
- 升高的FBXO2水平与各种恶性瘤中瘤细胞增殖,迁移和入侵的增加相关.
- FBXO2在癌症发展中的作用与其在UPS和SCF复合体中的功能有关.
结论:
- FBXO2 是恶性瘤发展和进展的一个重要因素.
- 了解FBXO2在癌症中的机制为新的治疗干预提供了潜力.
- 对FBXO2作用的进一步研究可以促进向癌症治疗.
更多相关视频
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
10.8K
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
861
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K